Loading

Structuring Partnerships for Success in Vaccine Development

June 18, 2025
Breakout Session
Infectious Disease and Vaccines
210B
What makes a partnership work in vaccine development? When is it the right stage to partner programs? How do you identify strategic partner fits? With its own unique ecosystem, vaccine development and partnerships can bring a set of challenges not always seen in the broader biopharma space. A handful of companies are taking on these challenges and laying the groundwork for success. In this panel, vaccine partnering veterans and leaders will answer key questions on the highlights of and obstacles with vaccine development partnerships and investments based on their vast experience. They will provide invaluable strategic insights on how companies, large and small, can partner efficiently for success in developing and commercializing vaccines to help protect global health.
Speakers
Tom Davidson
Vice Chairman, Co-President, Global Co-Head of Investment Banking
Leerink Partners
Hannah H. England, JD
Partner
Ropes & Gray
Laurie Gery, MBA
Head of Business Development & Licensing, Vaccines
Sanofi
Elaine O'Hara
Executive Vice President, Chief Strategy Officer
Novavax
Ryan Spencer
Chief Executive Officer
Dynavax
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS